Safety and Immunogenicity Study of Rift Valley Fever Vaccine

NCT00584194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

278

Enrollment

FED

Sponsor class

Conditions

Rift Valley Fever

Interventions

BIOLOGICAL: TSI-GSD 200 RVF Vaccine

Sponsor

U.S. Army Medical Research and Development Command